The CellArray: A method for multiplexed cellular assays

Information

  • Research Project
  • 6689368
  • ApplicationId
    6689368
  • Core Project Number
    R43CA103228
  • Full Project Number
    1R43CA103228-01
  • Serial Number
    103228
  • FOA Number
  • Sub Project Id
  • Project Start Date
    8/1/2003 - 22 years ago
  • Project End Date
    7/31/2004 - 21 years ago
  • Program Officer Name
    SWAIN, AMY L
  • Budget Start Date
    8/1/2003 - 22 years ago
  • Budget End Date
    7/31/2004 - 21 years ago
  • Fiscal Year
    2003
  • Support Year
    1
  • Suffix
  • Award Notice Date
    7/15/2003 - 22 years ago

The CellArray: A method for multiplexed cellular assays

DESCRIPTION (provided by applicant): The recent sequencing of the human genome will provide a wealth of gene sequence, structure, and organizational data. To harness information from this effort that will lead to effective medical therapies, techniques are necessary that distinguish the phenotypic differences of normal versus diseased cells at the molecular level. Specifically, technologies are needed that can rapidly and reliably measure the expression of molecular markers from large numbers of disease related cell types. The objective of this grant is to develop and validate a rapid and reproducible method for the multiplexed analysis of cell lines. A technique has been developed to grow, harvest, and store cells in thin tubes. The tubes are then assembled into an array and frozen sections derived from them can be mounted on slides and used directly for cell-based analyses (CellArray). The aims of this grant are to construct CellArrays containing the entire NCI anti-cancer cell line panel and validate it for protein and mRNA expression studies. The methods for CellArray construction are novel and covered by a granted U.S. patent. The NCI panel CellArrays will provide researchers with an invaluable tool for the rapid, reproducible, and economical analysis of multiple disease relevant cell lines.

IC Name
NATIONAL CANCER INSTITUTE
  • Activity
    R43
  • Administering IC
    CA
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    99200
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    396
  • Ed Inst. Type
  • Funding ICs
    NCI:99200\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    RAVEN BIOTECHNOLOGIES, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    SOUTH SAN FRANCISCO
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    94080
  • Organization District
    UNITED STATES